Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

172226

registered interest
date	06/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Learning Disability and Autism
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure the recommendations of the report by Sir Stephen Bubb, entitled, Winterbourne View - Time for Change are being implemented as soon as possible.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	219904
answer	answer is ministerial correction date of answer 13/01/2015 answer text <p>NHS England and the Department of Health are considering the report’s recommendations in the context of the ongoing, system-wide Transforming Care programme, convened in response to events at Winterbourne View Hospital. NHS England will respond to the report by Sir Stephen Bubb in early 2015.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 13/01/2015 15:31:30 answering member 1439 label Biography information for Norman Lamb
tabling member	4079 label Biography information for Julian Sturdy

390813

registered interest
date	16/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Bacterial Diseases: Mortality Rates
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Answer of 25 November 2014 to Question 215524, when Public Health England intends to publish data on the mortality rate for deaths in 2013 involving (a) C. difficile and (b) MRSA in (i) England and (ii) each NHS trust.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	7619
answer	answer is ministerial correction date of answer 22/07/2015 answer text <p>Public Health England intends to publish 30-day all-cause mortality following methicillin resistant <em>Staphylococcus aureus</em> (MRSA) bacteraemia, methicillin sensitive <em>Staphylococcus aureus</em> (MSSA) bacteraemia, <em>Escherichia coli</em> bacteraemia and <em>Clostridium difficile</em> infection in the autumn. Data will be broken down by National Health Service region and patient age and gender.</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 22/07/2015 15:52:20 answering member 3988 label Biography information for Ben Gummer
tabling member	4079 label Biography information for Julian Sturdy

416412

registered interest
date	04/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hospitals: Parking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department has taken to tackle expensive hospital car parking charges since the publication of its ground rules in August 2014.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	8619
answer	answer is ministerial correction date of answer 14/09/2015 answer text <p>Decisions on hospital car parking, including charging, are taken locally as National Health Service organisations have the autonomy to make decisions that best suit their local circumstances. However the NHS patient visitor and staff car parking principles published by the Department on 23 August 2014 provide clear direction and leadership and require NHS organisations to publish details of their car parking arrangements including financial information relating to the charges and income which allows patients and the public to hold the NHS locally to account where unfair parking charges occur.</p><p> </p><p><strong> </strong></p><p> </p><p>Information about the cost and availability of car parking across the NHS is published annually as part of two data collections - the Patient-Led Assessments of the Care Environment and the Estates Return Information Collection. This information is publicly available and will also help people hold their local hospitals to account.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 14/09/2015 15:58:32 answering member 1201 label Biography information for Alistair Burt
tabling member	4079 label Biography information for Julian Sturdy

422666

registered interest
date	20/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Haematological Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will take further steps to support Anthony Nolan's Destination Cure campaign.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	12658
answer	answer is ministerial correction date of answer 28/10/2015 answer text <br /> <br /><p>Since 2011, the Department of Health has provided our delivery partners, NHS Blood and Transplant and Anthony Nolan, a total of £16 million in additional, new funding to improve stem cell transplantation services in the United Kingdom. A further £3 million investment was announced in March 2015.</p><br /><p>The Government remains committed to improving stem cell transplantation services and doing all we can to help those in need of a transplant to find a suitable donor. The report ‘Destination Cure – arriving at a better future’ from Anthony Nolan provides a timely contribution to this work.</p><br /> answering member constituency Battersea answering member printed Jane Ellison question first answered 28/10/2015 17:09:26 answering member 3918 label Biography information for Jane Ellison
tabling member	4079 label Biography information for Julian Sturdy

422982

registered interest
date	21/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Clinical Commissioning Groups
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what progress he has made on reform of the NHS funding formula to clinical commissioning groups.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	12812
answer	answer is ministerial correction date of answer 29/10/2015 answer text <p>NHS England has responsibility for determining allocations to clinical commissioning groups (CCGs). The Advisory Committee on Resource Allocation, an independent advisory group, is undertaking a full review of the formula used to determine allocations for individual CCGs. The review is nearing completion and we expect their recommendations to be presented at the NHS England Board meeting in December</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 29/10/2015 16:25:35 answering member 1201 label Biography information for Alistair Burt
tabling member	4079 label Biography information for Julian Sturdy

433830

registered interest
date	01/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccine Damage Payment Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effectiveness of the Vaccine Damage Payment scheme.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	902566
answer	answer is ministerial correction date of answer 07/12/2015 answer text <p>Policy responsibility for the Vaccine Damage Payment Scheme transferred to the Department of Health from the Department for Work and Pensions (DWP) in May 2014 although DWP continues to administer this scheme. The scheme was last revised in 2007 and no assessment of effectiveness has been made since that date.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 07/12/2015 13:53:40 answering member 3918 label Biography information for Jane Ellison
tabling member	4079 label Biography information for Julian Sturdy

436266

registered interest
date	08/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he expects Orkambi to be appraised by NICE.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	19234
answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance on the use of Orkambi (lumacaftor in combination with ivacaftor) for the treatment of cystic fibrosis in people who are homozygous for the F508del mutation. NICE’s anticipated publication date for this guidance is July 2016. Further information is available at:</p><br /><p>www.nice.org.uk/guidance/indevelopment/gid-tag530</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 16:20:22 answering member 4020 label Biography information for George Freeman
tabling member	4079 label Biography information for Julian Sturdy

436267

registered interest
date	08/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what representations he has received on reforming of NICE's procedure for appraisal of medicines.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	19235
answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>We receive representations about the National Institute for Health and Care Excellence’s (NICE) technology appraisal programme from hon. Members, members of the public, clinicians and the pharmaceutical industry.</p><br /><p>NICE is the independent body that provides guidance on the prevention and treatment of ill health and the promotion of good health and social care and is responsible for its own processes and methodology.</p><br /><p>NICE regularly reviews these and its internationally renowned technology appraisal programme has evolved constantly to meet new challenges. NICE has demonstrated its ability to adapt to changes in the health and care environment, and we expect it will continue to evolve in the future, in particular through the recommendations of the Accelerated Access Review which NICE is centrally involved in.</p><br /><p>Further guidance on NICE’s processes of technology appraisal is available at:</p><br /><p>www.nice.org.uk/article/pmg19/chapter/Foreword</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 16:28:02 answering member 4020 label Biography information for George Freeman
tabling member	4079 label Biography information for Julian Sturdy

456540

registered interest
date	01/03/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmacy: Closures
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent discussions he has held with pharmacy patients on the closure of community pharmacies.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	29298
answer	answer is ministerial correction date of answer 07/03/2016 answer text <p>Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.</p><p> </p><p>The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.</p><p> </p><p>Our proposals are about improving services for patients and the public and securing efficiencies and savings. A consequence may be the closure of some pharmacies but that is not our aim. We are not able to assess which pharmacies may close or the number of people who may lose their jobs, because we do not know the financial viability of individual businesses or the extent to which they derive income from services commissioned locally by the NHS or local authorities or have non-NHS related income.</p><p> </p><p>We are consulting the Pharmaceutical Services Negotiating Committee and others, including patient and public representatives on our proposals. An impact assessment will be completed to inform final decisions and published in due course.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt grouped question UIN 29299 question first answered 07/03/2016 12:32:46 answering member 1201 label Biography information for Alistair Burt
tabling member	4079 label Biography information for Julian Sturdy

456541

registered interest
date	01/03/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmacy: Impact Assessments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of proposals for changes to Government policy on community pharmacies.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	29299
answer	answer is ministerial correction date of answer 07/03/2016 answer text <p>Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.</p><p> </p><p>The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.</p><p> </p><p>Our proposals are about improving services for patients and the public and securing efficiencies and savings. A consequence may be the closure of some pharmacies but that is not our aim. We are not able to assess which pharmacies may close or the number of people who may lose their jobs, because we do not know the financial viability of individual businesses or the extent to which they derive income from services commissioned locally by the NHS or local authorities or have non-NHS related income.</p><p> </p><p>We are consulting the Pharmaceutical Services Negotiating Committee and others, including patient and public representatives on our proposals. An impact assessment will be completed to inform final decisions and published in due course.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt grouped question UIN 29298 question first answered 07/03/2016 12:32:47 answering member 1201 label Biography information for Alistair Burt
tabling member	4079 label Biography information for Julian Sturdy